-
1
-
-
0026707370
-
Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia
-
Allen AM, MacGregor DP, Chai SY, Donnan GA, Kaczymarzyk S, Richardson K, Kalnins R, Ireton J, Mendelsohn FAO. 1992. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann Neurol 32:339-344.
-
(1992)
Ann Neurol
, vol.32
, pp. 339-344
-
-
Allen, A.M.1
MacGregor, D.P.2
Chai, S.Y.3
Donnan, G.A.4
Kaczymarzyk, S.5
Richardson, K.6
Kalnins, R.7
Ireton, J.8
Mendelsohn, F.A.O.9
-
2
-
-
0032168399
-
Angiotensin receptors in the nervous system
-
Allen AM, Moeller I, Jenkins A, Zhuo J, Aldred GP, Chai SY, Mendelsohn FAO. 1998. Angiotensin receptors in the nervous system. Brain Res Bull 47:17-28.
-
(1998)
Brain Res Bull
, vol.47
, pp. 17-28
-
-
Allen, A.M.1
Moeller, I.2
Jenkins, A.3
Zhuo, J.4
Aldred, G.P.5
Chai, S.Y.6
Mendelsohn, F.A.O.7
-
3
-
-
0027331917
-
The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls
-
Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH. 1993. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18:1175-1177.
-
(1993)
Neurochem Res
, vol.18
, pp. 1175-1177
-
-
Andrew, R.1
Watson, D.G.2
Best, S.A.3
Midgley, J.M.4
Wenlong, H.5
Petty, R.K.H.6
-
4
-
-
0028274123
-
The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat
-
Banks RJA, Mozley L, Dourrish CT. 1994. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat. Neuroscience 58:799-805.
-
(1994)
Neuroscience
, vol.58
, pp. 799-805
-
-
Banks, R.J.A.1
Mozley, L.2
Dourrish, C.T.3
-
5
-
-
0029125857
-
Aging, energy, and oxidative stress in neurodegenerative diseases
-
Beal MF. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
-
(1995)
Ann Neurol
, vol.38
, pp. 357-366
-
-
Beal, M.F.1
-
6
-
-
0031983817
-
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro
-
Benzie IFF, Tomlinson B. 1998. Antioxidant power of angiotensin- converting enzyme inhibitors in vitro. Br J Clin Pharmacol 45:168-169.
-
(1998)
Br J Clin Pharmacol
, vol.45
, pp. 168-169
-
-
Benzie, I.F.F.1
Tomlinson, B.2
-
9
-
-
0019990607
-
Differential distribution of immunoreactive angiotensin and angiotensin-converting enzyme in rat brain
-
Brownfield MS, Reid IA, Ganten D, Ganong WF. 1982. Differential distribution of immunoreactive angiotensin and angiotensin-converting enzyme in rat brain. Neuroscience 7:1759-1769.
-
(1982)
Neuroscience
, vol.7
, pp. 1759-1769
-
-
Brownfield, M.S.1
Reid, I.A.2
Ganten, D.3
Ganong, W.F.4
-
10
-
-
0023100936
-
Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography
-
Chai SY, Mendelsohn FAO, Paxinos G. 1987. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 20:615-627.
-
(1987)
Neuroscience
, vol.20
, pp. 615-627
-
-
Chai, S.Y.1
Mendelsohn, F.A.O.2
Paxinos, G.3
-
11
-
-
0016139538
-
Mass fragmentography of dopamine and 6-OH-dopamine. Application to the determination of dopamine in human brain biopsies fron the caudate nucleus
-
Curtius HC, Wolhensberger M, Steinmann B, Redweik S. 1974. Mass fragmentography of dopamine and 6-OH-dopamine. Application to the determination of dopamine in human brain biopsies fron the caudate nucleus. J Chromatogr 99:529-540.
-
(1974)
J Chromatogr
, vol.99
, pp. 529-540
-
-
Curtius, H.C.1
Wolhensberger, M.2
Steinmann, B.3
Redweik, S.4
-
12
-
-
0019155471
-
Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain
-
Evered MD, Robinson MM, Richardson MA. 1980. Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain. Eur J Pharmacol 68: 443-449.
-
(1980)
Eur J Pharmacol
, vol.68
, pp. 443-449
-
-
Evered, M.D.1
Robinson, M.M.2
Richardson, M.A.3
-
13
-
-
0030009361
-
Different effects of thiol and non-thiol angiotensin-converting enzyme inhibitors on cooper-induced lipid and protein oxidative modification
-
Fernandes AC, Filipe PM, Freitas JP, Manso CF. 1996. Different effects of thiol and non-thiol angiotensin-converting enzyme inhibitors on cooper-induced lipid and protein oxidative modification. Free Rad Biol Med 20:507-514.
-
(1996)
Free Rad Biol Med
, vol.20
, pp. 507-514
-
-
Fernandes, A.C.1
Filipe, P.M.2
Freitas, J.P.3
Manso, C.F.4
-
14
-
-
2342463048
-
Renin-angiotensin system as a therapeutic target in managing atherosclerosis
-
Ferrario CM, Richmond RS, Smith R, Levy P, Strawn WB, Kivlighn S. 2004. Renin-angiotensin system as a therapeutic target in managing atherosclerosis. Am J Ther 11:44-53.
-
(2004)
Am J Ther
, vol.11
, pp. 44-53
-
-
Ferrario, C.M.1
Richmond, R.S.2
Smith, R.3
Levy, P.4
Strawn, W.B.5
Kivlighn, S.6
-
15
-
-
0028278760
-
Origin of the angiotensin II secreted by cells
-
Ganong WF. 1994. Origin of the angiotensin II secreted by cells. Proc Soc Exp Biol Med 205:213-219.
-
(1994)
Proc Soc Exp Biol Med
, vol.205
, pp. 213-219
-
-
Ganong, W.F.1
-
16
-
-
0037443073
-
Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflamogen lipopolysaccharide: Relevance to the etiology of Parkinson's disease
-
Gao HM, Hong JS, Zhang W, Liu B. 2003a. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflamogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 23: 1228-1236.
-
(2003)
J Neurosci
, vol.23
, pp. 1228-1236
-
-
Gao, H.M.1
Hong, J.S.2
Zhang, W.3
Liu, B.4
-
17
-
-
84863135790
-
Synergistic dopaminergic neurotoxicity of MPTP and inflamogen lipopolysaccharide: Relevance to the etiology of Parkinson's disease
-
Gao HM, Liu B, Zhang W, Hong JS. 2003b. Synergistic dopaminergic neurotoxicity of MPTP and inflamogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. FASEB J 17:1957-1959.
-
(2003)
FASEB J
, vol.17
, pp. 1957-1959
-
-
Gao, H.M.1
Liu, B.2
Zhang, W.3
Hong, J.S.4
-
18
-
-
0029670896
-
2 receptor subtype levels in brain regions from patients with neurodegenetative disorders
-
2 receptor subtype levels in brain regions from patients with neurodegenetative disorders. Eur J Pharmacol 297:299-306.
-
(1996)
Eur J Pharmacol
, vol.297
, pp. 299-306
-
-
Ge, J.1
Barnes, N.M.2
-
19
-
-
0347989300
-
The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: From observations to mechanisms
-
Gendron L, Payet MD, Gallo-Payet N. 2003. The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. J Mol Endocrinol 31:359-372.
-
(2003)
J Mol Endocrinol
, vol.31
, pp. 359-372
-
-
Gendron, L.1
Payet, M.D.2
Gallo-Payet, N.3
-
21
-
-
0032511134
-
Mechanism of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine
-
Glinka Y, Tipton KF, Youdim MBH. 1998. Mechanism of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur J Pharmacol 351:121-129.
-
(1998)
Eur J Pharmacol
, vol.351
, pp. 121-129
-
-
Glinka, Y.1
Tipton, K.F.2
Youdim, M.B.H.3
-
22
-
-
0034677947
-
NADPH oxidase. Role in cardiovascular biology and disease
-
Griendling KK, Sorescu D, Ushio-Fukai M. 2000. NADPH oxidase. Role in cardiovascular biology and disease. Circ Res 86:494-501.
-
(2000)
Circ Res
, vol.86
, pp. 494-501
-
-
Griendling, K.K.1
Sorescu, D.2
Ushio-Fukai, M.3
-
23
-
-
84985280160
-
The efficiency of systematic sampling in stereology and its prediction
-
Gundersen HJG, Jensen EB. 1987. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147:229-263.
-
(1987)
J Microsc
, vol.147
, pp. 229-263
-
-
Gundersen, H.J.G.1
Jensen, E.B.2
-
24
-
-
0023913503
-
Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
-
Gundersen HJG, Bendsen TF, Korbo L, Marcussen N, Moller A, Nielsen K. 1988. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APIMS 96:379-394.
-
(1988)
APIMS
, vol.96
, pp. 379-394
-
-
Gundersen, H.J.G.1
Bendsen, T.F.2
Korbo, L.3
Marcussen, N.4
Moller, A.5
Nielsen, K.6
-
25
-
-
1842788061
-
Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: Role of ferrous and ferric ions
-
Hermida-Ameijeiras A, Méndez-Álvarez E, Sanchez-Iglesias S, Sanmartín-Suárez C, Soto-Otero R. 2004. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int 45:103-116.
-
(2004)
Neurochem Int
, vol.45
, pp. 103-116
-
-
Hermida-Ameijeiras, A.1
Méndez-Álvarez, E.2
Sanchez-Iglesias, S.3
Sanmartín-Suárez, C.4
Soto-Otero, R.5
-
26
-
-
2342639020
-
The potential role of angiotensin converting enzyme inhibition in peripheral arterial disease
-
Hirsch AT, Duprez D. 2003. The potential role of angiotensin converting enzyme inhibition in peripheral arterial disease. Vasc Med 8:273-278.
-
(2003)
Vasc Med
, vol.8
, pp. 273-278
-
-
Hirsch, A.T.1
Duprez, D.2
-
27
-
-
0001941442
-
Endogenous toxins as potential etiologic agents in Parkinson's disease
-
Ellenberg JH, Koller WC, Langston JW, editors. New York: Marcel Dekker.
-
Irwin I, Langston JW. 1995. Endogenous toxins as potential etiologic agents in Parkinson's disease. In: Ellenberg JH, Koller WC, Langston JW, editors. Etiology of Parkinson's disease. New York: Marcel Dekker. p 153-201.
-
(1995)
Etiology of Parkinson's Disease
, pp. 153-201
-
-
Irwin, I.1
Langston, J.W.2
-
28
-
-
0029414750
-
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease
-
Jellinger K, Linert L, Kienzl E, Herlinger E, Youdim MBH. 1995. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease. J Neural Transm 46: 297-314.
-
(1995)
J Neural Transm
, vol.46
, pp. 297-314
-
-
Jellinger, K.1
Linert, L.2
Kienzl, E.3
Herlinger, E.4
Youdim, M.B.H.5
-
29
-
-
0031027898
-
Angiotensin-converting enzyme modulates dopamine turnover in the striatum
-
Jenkins TA, Mendelsohn FAO, Chai SY. 1997. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem 68:1304-1311.
-
(1997)
J Neurochem
, vol.68
, pp. 1304-1311
-
-
Jenkins, T.A.1
Mendelsohn, F.A.O.2
Chai, S.Y.3
-
30
-
-
0033038787
-
Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in MPTP-treated mouse
-
Jenkins TA, Wong JYF, Howells DW, Mendelsohn FAO. 1999. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in MPTP-treated mouse. J Neurochem 73:214-219.
-
(1999)
J Neurochem
, vol.73
, pp. 214-219
-
-
Jenkins, T.A.1
Wong, J.Y.F.2
Howells, D.W.3
Mendelsohn, F.A.O.4
-
31
-
-
0037378026
-
Oxidative stress in Parkinson's disease
-
Jenner P. 2003. Oxidative stress in Parkinson's disease. Ann Neurol 53: S26-S38.
-
(2003)
Ann Neurol
, vol.53
-
-
Jenner, P.1
-
32
-
-
0014740618
-
Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons
-
Jonsson G, Sachs C. 1970. Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons. Eur J Pharmacol 9:141-155.
-
(1970)
Eur J Pharmacol
, vol.9
, pp. 141-155
-
-
Jonsson, G.1
Sachs, C.2
-
34
-
-
0028170674
-
Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease
-
Konings CH, Kuiper MA, Bergmans PL, Grijpma AM, van Kamp GJ, Wolters EC. 1994. Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease. Clin Chim Acta 23:101-106.
-
(1994)
Clin Chim Acta
, vol.23
, pp. 101-106
-
-
Konings, C.H.1
Kuiper, M.A.2
Bergmans, P.L.3
Grijpma, A.M.4
Van Kamp, G.J.5
Wolters, E.C.6
-
35
-
-
0028916715
-
Free radical-generated neurotoxicity of 6-hydroxydopamine
-
Kumar R, Agarwal AK, Seth PK. 1995. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 64:1703-1707.
-
(1995)
J Neurochem
, vol.64
, pp. 1703-1707
-
-
Kumar, R.1
Agarwal, A.K.2
Seth, P.K.3
-
36
-
-
0037099766
-
Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson disease
-
Lin J-J, Yueh K-C, Chang D-C, Lin S-Z. 2002. Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson disease. J Neurol Sci 199:25-29.
-
(2002)
J Neurol Sci
, vol.199
, pp. 25-29
-
-
Lin, J.-J.1
Yueh, K.-C.2
Chang, D.-C.3
Lin, S.-Z.4
-
37
-
-
0034095178
-
Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kinogen-deficient rats
-
Liu YH, Yang XP, Mehta D, Bulagannawar M, Scicli GM, Carretero OA. 2000. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kinogen-deficient rats. Am J Physiol Heart Circ Physiol 278:H507-H514.
-
(2000)
Am J Physiol Heart Circ Physiol
, vol.278
-
-
Liu, Y.H.1
Yang, X.P.2
Mehta, D.3
Bulagannawar, M.4
Scicli, G.M.5
Carretero, O.A.6
-
38
-
-
27444437425
-
Influencia del sistema renina-angiotensina (RAS) sobre la degeneracion del sistema nigroestriatal dopaminergico inducida por 6-OHDA
-
PhD Thesis, Universidad de Santiago de Compostela
-
Lopez-Real A. 2003. Influencia del sistema renina-angiotensina (RAS) sobre la degeneracion del sistema nigroestriatal dopaminergico inducida por 6-OHDA. In: Analisis experimental de nuevas estrategias terapeuticas para la enfermedad de Parkinson. PhD Thesis, Universidad de Santiago de Compostela. p 173-187.
-
(2003)
Analisis Experimental de Nuevas Estrategias Terapeuticas para la Enfermedad de Parkinson
, pp. 173-187
-
-
Lopez-Real, A.1
-
39
-
-
0025110014
-
Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endotelial cells
-
Mak IT, Freedman AM, Dickens BF, Weglicki WB. 1990. Protective effects of sulfhydryl-containing angiotensin-converting enzyme inhibitors against free radical injury in endotelial cells. Biochem Pharmacol 40:2169-2175.
-
(1990)
Biochem Pharmacol
, vol.40
, pp. 2169-2175
-
-
Mak, I.T.1
Freedman, A.M.2
Dickens, B.F.3
Weglicki, W.B.4
-
40
-
-
0018178434
-
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
-
Markwell MAK, Haas SM, Bieber LL, Tolbert NE. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210.
-
(1978)
Anal Biochem
, vol.87
, pp. 206-210
-
-
Markwell, M.A.K.1
Haas, S.M.2
Bieber, L.L.3
Tolbert, N.E.4
-
41
-
-
0037409427
-
The brain renin-angiotensin system: Location and physiological roles
-
McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FAO, Chai SY. 2003. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35:901-918.
-
(2003)
Int J Biochem Cell Biol
, vol.35
, pp. 901-918
-
-
McKinley, M.J.1
Albiston, A.L.2
Allen, A.M.3
Mathai, M.L.4
May, C.N.5
McAllen, R.M.6
Oldfield, B.J.7
Mendelsohn, F.A.O.8
Chai, S.Y.9
-
42
-
-
0027156129
-
Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rat
-
Mendelsohn FAO, Jenkins TA, Berkovic SF. 1993. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rat. Brain Res 613:221-229.
-
(1993)
Brain Res
, vol.613
, pp. 221-229
-
-
Mendelsohn, F.A.O.1
Jenkins, T.A.2
Berkovic, S.F.3
-
43
-
-
0027426080
-
Angiotensin-converting enzyme inhibitors as oxygen free radical scavengers
-
Mira ML, Silva MM, Queiroz MJ, Manso CF. 1993. Angiotensin-converting enzyme inhibitors as oxygen free radical scavengers. Free Rad Res Commun 19:173-181.
-
(1993)
Free Rad Res Commun
, vol.19
, pp. 173-181
-
-
Mira, M.L.1
Silva, M.M.2
Queiroz, M.J.3
Manso, C.F.4
-
44
-
-
0035949650
-
Are ACE inhibitors a "magic bullet" against oxidative stress?
-
Münzel T, Keany JF. 2001. Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 104:1571-1577.
-
(2001)
Circulation
, vol.104
, pp. 1571-1577
-
-
Münzel, T.1
Keany, J.F.2
-
45
-
-
0030795401
-
Free radical scavenging properties of alecepril metabolites and Lisinopril
-
Noda Y, Mori A, Packer L. 1997. Free radical scavenging properties of alecepril metabolites and Lisinopril. Res Commun Mol Pathol Pharmacol 196:125-136.
-
(1997)
Res Commun Mol Pathol Pharmacol
, vol.196
, pp. 125-136
-
-
Noda, Y.1
Mori, A.2
Packer, L.3
-
46
-
-
0034573392
-
Induction and activation by zinc of NADH oxidase in cultured cortical neurons and astrocytes
-
Noh KM, Koh JY. 2000. Induction and activation by zinc of NADH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20: RC111(1-5).
-
(2000)
J Neurosci
, vol.20
, Issue.1-5
-
-
Noh, K.M.1
Koh, J.Y.2
-
47
-
-
4544274907
-
Brain angiotensin II and synaptic transmission
-
Pan H-L. 2004. Brain angiotensin II and synaptic transmission. Neuroscientist 10:422-431.
-
(2004)
Neuroscientist
, vol.10
, pp. 422-431
-
-
Pan, H.-L.1
-
48
-
-
0031685422
-
Experimental developments in movement disorders: Uptake on proposed free radical mechanisms
-
Przedborski S, Jackson-Lewis V. 1998. Experimental developments in movement disorders: uptake on proposed free radical mechanisms. Curr Opm Neurol 11:335-339.
-
(1998)
Curr Opm Neurol
, vol.11
, pp. 335-339
-
-
Przedborski, S.1
Jackson-Lewis, V.2
-
49
-
-
0019351359
-
Immunoreactivity for angiotensin II-like peptide in the human brain
-
Quinlan JT, Phillips MI. 1981. Immunoreactivity for angiotensin II-like peptide in the human brain. Brain Res 205:212-218.
-
(1981)
Brain Res
, vol.205
, pp. 212-218
-
-
Quinlan, J.T.1
Phillips, M.I.2
-
50
-
-
0032980840
-
Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats
-
Ravati A, Junker V, Kouklei M, Ahlemeyer B, Culmsee C, Kriegstein AR. 1999. Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. Eur J Pharmacol 373:21-33.
-
(1999)
Eur J Pharmacol
, vol.373
, pp. 21-33
-
-
Ravati, A.1
Junker, V.2
Kouklei, M.3
Ahlemeyer, B.4
Culmsee, C.5
Kriegstein, A.R.6
-
51
-
-
0742287703
-
Tissue renin angiotensin systems
-
Re RN. 2004. Tissue renin angiotensin systems. Med Clin North Am 88:19-38.
-
(2004)
Med Clin North Am
, vol.88
, pp. 19-38
-
-
Re, R.N.1
-
52
-
-
0034023229
-
The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease
-
Reardon KA, Mendelsohn FA, Chai SY, Home MK. 2000. The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. Aust N Z Med 30:48-53.
-
(2000)
Aust N Z Med
, vol.30
, pp. 48-53
-
-
Reardon, K.A.1
Mendelsohn, F.A.2
Chai, S.Y.3
Home, M.K.4
-
53
-
-
0035020470
-
Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: Similarities with cell loss in Parkinson's disease
-
Rodriguez M, Barroso-Chinea P, Abdala P, Obeso J, Gonzalez-Hernandez T. 2001. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson's disease. Exp Neurol 169:163-181.
-
(2001)
Exp Neurol
, vol.169
, pp. 163-181
-
-
Rodriguez, M.1
Barroso-Chinea, P.2
Abdala, P.3
Obeso, J.4
Gonzalez-Hernandez, T.5
-
54
-
-
4644306054
-
Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors
-
Rodriguez-Pallares J, Quiroz CR, Parga JA, Guerra MJ, Labandeira-Garcia JL. 2004. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. Eur J Neurosci 20:1489-1498.
-
(2004)
Eur J Neurosci
, vol.20
, pp. 1489-1498
-
-
Rodriguez-Pallares, J.1
Quiroz, C.R.2
Parga, J.A.3
Guerra, M.J.4
Labandeira-Garcia, J.L.5
-
55
-
-
0023787567
-
Differential angiotensin converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography
-
Sakaguchi K, Chai SY, Johnston CI, Mendelsohn FAO. 1988. Differential angiotensin converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography. Neuroendocrinology 48:223-228.
-
(1988)
Neuroendocrinology
, vol.48
, pp. 223-228
-
-
Sakaguchi, K.1
Chai, S.Y.2
Johnston, C.I.3
Mendelsohn, F.A.O.4
-
56
-
-
33947462600
-
Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine
-
Senoh S, Creveling CR, Udenfriend S, Witkop B. 1959. Chemical, enzymatic and metabolic studies on the mechanism of oxidation of dopamine. J Am Chem Soc 81:6236-6240.
-
(1959)
J Am Chem Soc
, vol.81
, pp. 6236-6240
-
-
Senoh, S.1
Creveling, C.R.2
Udenfriend, S.3
Witkop, B.4
-
57
-
-
0142011158
-
NADPH oxidase immunoreactivity in the mouse brain
-
Serrano F, Kolluri NS, Wientjes FB, Card JP, Klann E. 2003. NADPH oxidase immunoreactivity in the mouse brain. Brain Res 988:193-198.
-
(2003)
Brain Res
, vol.988
, pp. 193-198
-
-
Serrano, F.1
Kolluri, N.S.2
Wientjes, F.B.3
Card, J.P.4
Klann, E.5
-
58
-
-
1542647634
-
Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: Its role in clinical practice
-
Sica DA. 2003. Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice. J Clin Hypertens 2003:414-420.
-
(2003)
J Clin Hypertens
, vol.2003
, pp. 414-420
-
-
Sica, D.A.1
-
59
-
-
0021175531
-
Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase
-
Skidgel RA, Engelbrecht S, Johnson AR, Erdos EG. 1984. Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5:769-776.
-
(1984)
Peptides
, vol.5
, pp. 769-776
-
-
Skidgel, R.A.1
Engelbrecht, S.2
Johnson, A.R.3
Erdos, E.G.4
-
60
-
-
0002799850
-
Angiotensin I converting enzyme and its role in neuropeptide metabolism
-
Turner AJ, editor. New York: Ellis Horwood
-
Skidgel RA, Defendini R, Erdos EG. 1987. Angiotensin I converting enzyme and its role in neuropeptide metabolism. In: Turner AJ, editor. Neuropeptides and their peptidases. New York: Ellis Horwood. p 165-182.
-
(1987)
Neuropeptides and Their Peptidases
, pp. 165-182
-
-
Skidgel, R.A.1
Defendini, R.2
Erdos, E.G.3
-
61
-
-
0342369569
-
Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: Potential implication in relation to the pathogenesis of Parkinson's disease
-
Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras A, Muñoz-Patiño A, Labandeira-Garcia JL. 2000. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 74:1605-1612.
-
(2000)
J Neurochem
, vol.74
, pp. 1605-1612
-
-
Soto-Otero, R.1
Méndez-Álvarez, E.2
Hermida-Ameijeiras, A.3
Muñoz-Patiño, A.4
Labandeira-Garcia, J.L.5
-
62
-
-
0036639946
-
Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: Relevance for Parkinson's disease
-
Soto-Otero R, Mẽndez-Alvarez E, Hermida-Ameijeiras A, Lõpez-Real AM, Labandeira-Garcia JL. 2002. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem Pharmacol 64:125-135.
-
(2002)
Biochem Pharmacol
, vol.64
, pp. 125-135
-
-
Soto-Otero, R.1
Mẽndez-Alvarez, E.2
Hermida-Ameijeiras, A.3
Lõpez-Real, A.M.4
Labandeira-Garcia, J.L.5
-
63
-
-
0346895374
-
Therapeutic potential of renin inhibitors in the management of cardiovascular disorders
-
Stanton A. 2003. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. Am J Cardiovasc Drugs 3:389-394.
-
(2003)
Am J Cardiovasc Drugs
, vol.3
, pp. 389-394
-
-
Stanton, A.1
-
64
-
-
0027241894
-
Comparative free radical scavenging action of angiotensine-converting enzyme inhibitors with and without the sulfhydryl radical
-
Suzuki S, Sato H, Shimada H, Takashima N, Arakawa M. 1993. Comparative free radical scavenging action of angiotensine-converting enzyme inhibitors with and without the sulfhydryl radical. Pharmacology 47:61-65.
-
(1993)
Pharmacology
, vol.47
, pp. 61-65
-
-
Suzuki, S.1
Sato, H.2
Shimada, H.3
Takashima, N.4
Arakawa, M.5
-
65
-
-
0141791599
-
Pharmacologic blockade of the renin-angiotensin system: Vascular benefits beyond commoly understood pharmacologic actions
-
Tsikouris JP, Cox CD. 2003. Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commoly understood pharmacologic actions. Pharmacotherapy 23:1141-1152.
-
(2003)
Pharmacotherapy
, vol.23
, pp. 1141-1152
-
-
Tsikouris, J.P.1
Cox, C.D.2
-
66
-
-
0031741456
-
Captopril inhibits both dopaminergic and cholinergic neurotransmission in the central nervous system
-
Tsuda K, Tsuda S, Nishio I, Masuyama Y, Goldstein M. 1998. Captopril inhibits both dopaminergic and cholinergic neurotransmission in the central nervous system. Clin Exp Pharmacol Physiol 25:904-907.
-
(1998)
Clin Exp Pharmacol Physiol
, vol.25
, pp. 904-907
-
-
Tsuda, K.1
Tsuda, S.2
Nishio, I.3
Masuyama, Y.4
Goldstein, M.5
-
67
-
-
3042595343
-
NADPH oxidase contributes to angiotensin II signalling in the nucleus tractus solitarius
-
Wang G, Anrather J, Huang J, Speth RC, Pickel V, Iadecola C. 2004. NADPH oxidase contributes to angiotensin II signalling in the nucleus tractus solitarius. J Neurosci 24:5516-5524.
-
(2004)
J Neurosci
, vol.24
, pp. 5516-5524
-
-
Wang, G.1
Anrather, J.2
Huang, J.3
Speth, R.C.4
Pickel, V.5
Iadecola, C.6
-
69
-
-
0026339976
-
Unbiased stereological estimation of the total number of neurons of the rat hippocampus using the optical fractionator
-
West MJ, Slomianka L, Gundersen HJG. 1991. Unbiased stereological estimation of the total number of neurons of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
-
(1991)
Anat Rec
, vol.231
, pp. 482-497
-
-
West, M.J.1
Slomianka, L.2
Gundersen, H.J.G.3
|